AbbVie Inc. is an American pharmaceutical company headquartered in North Chicago, Illinois. It is ranked sixth on the list of largest biomedical companies by revenue. In 2023, the company's seat in Forbes Global 2000 was 74. The company's primary product is Humira, administered via injection. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for AbbVie (United Kingdom), United Kingdom, covering academic research published from 2013 to 2023. Read More.
Open Access Percentage
77%
Total
Publications
141
Total Open
Publications
109
Total
Citations
1.4K
Open Access
Percentage
77%
Total
Publications
141
Total Open
Publications
109
Total
Citations
1.4K
Breakdown
Publisher Open
40%
Both
30%
Other Platform Open
8%
Closed
22%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 20%
20
Hybrid 43%
42
No Guarantees 37%
36
Other Platform Open
Domain 77%
41
Institution 38%
20
Preprint 2%
1
Public 2%
1
Other Internet 2%
1
Other Platform Locations
Name | Platform Type | Publications |
---|---|---|
PubMed Central | Domain | 41 |
Europe PMC | Domain | 14 |
KU Leuven - Lirias | Institution | 6 |
whiterose.ac.uk OAI-PMH Repository | Institution | 5 |
University of Leeds, The University of Sheffield, University of York - White Rose Research Online | Institution | 4 |
University College London - UCL Discovery | Institution | 4 |
University of Oxford - Oxford University Research Archive (ORA) | Institution | 3 |
University of Dundee - Discovery Research Portal | Institution | 2 |
University of Bristol - Bristol Research | Institution | 2 |
University of Bath - University of Bath Research Portal | Institution | 2 |